Physiologically Based Pharmacokinetic Modeling of Caffeine in Preterm Neonates: Influence of Renal Function and Impairment on Dosing
The Journal of Clinical Pharmacology · 2026-01 · 66 (1)
DOI: 10.1002/jcph.70135 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, online erschienen am 27.11.2025. Verfasst von Nolan Thomas und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Practice and Translational Research Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA. Hauptthemen laut MEDLINE: Caffeine, Infant, Premature, Models, Biological, Kidney. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Currently, the same weight‐based caffeine citrate dosing regimen is applied to all neonates. However, due to differences in growth trajectories by gestational age (GA) and altered caffeine elimination in neonates with renal injury, optimal dosing regimens may differ. In this study, we refined the existing physiologically based pharmacokinetic (PBPK) model for caffeine in preterm neonates (GA 25–32 weeks) using Simcyp to evaluate dosing across varying ages and renal function. Real‐world data were used to generate weight‐for‐age growth curves and create virtual preterm populations. CYP1A2 ontogeny model was updated to better reflect the reduced metabolic activity of caffeine in preterm neonates. A 13.7‐fold increase in glomerular filtration rate‐adjusted renal clearance was needed to match observed data. Additionally, a higher volume of distribution (0.96 L/kg) was required to account for increased body water. The final model was verified using clinical pharmacokinetic data and used to simulate plasma concentration–time profiles. Our simulations showed that more premature neonates (≤28 weeks GA) may require lower weight‐based maintenance dosing (8 mg/kg) compared with those with higher GA (10 mg/kg), and may also require an increase in doses after 4–6 weeks of therapy to maintain therapeutic levels. Neonates with significantly reduced renal function (25% of normal) may need a two‐ to threefold dose reduction. Future studies should aim to define optimal therapeutic targets, as caffeine use continues to expand.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacy Practice and Translational Research Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA.
- Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Zitieren
APA
Thomas, N., Harer, M. W., & Lim, S. Y. (2026). Physiologically Based Pharmacokinetic Modeling of Caffeine in Preterm Neonates: Influence of Renal Function and Impairment on Dosing. The Journal of Clinical Pharmacology, 66(1). https://doi.org/10.1002/jcph.70135
Vancouver
Thomas N, Harer MW, Lim SY. Physiologically Based Pharmacokinetic Modeling of Caffeine in Preterm Neonates: Influence of Renal Function and Impairment on Dosing. The Journal of Clinical Pharmacology. 2026;66(1). doi:10.1002/jcph.70135
BibTeX
@article{Thomas2026,
author = {Thomas, Nolan and Harer, Matthew W and Lim, Sin Yin},
title = {Physiologically Based Pharmacokinetic Modeling of Caffeine in Preterm Neonates: Influence of Renal Function and Impairment on Dosing},
journal = {The Journal of Clinical Pharmacology},
year = {2026},
volume = {66},
number = {1},
doi = {10.1002/jcph.70135}
}
EUVIMED